It remains to be determined what effect selectively targeting Stat4 in myeloid cells, neurons or glia may have on declines in long-term, activity-dependent synaptic plasticity and cognition in normal aging or neurodegenerative diseases. Here, STAT4 is linked to neurodegenerative disease.